Genenta Science S.p.A. (GNTA)
NASDAQ·Healthcare·Biotechnology
$0.68
-7.82%
Mkt Cap $16.41M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.36 | -$0.36 | +0.00% | — | — |
| Q1 2026 Feb 25, 2026 | — | — | — | -$0.36 | -$0.36 | +0.00% | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$0.24 | — | — | — |
| Q2 2024 Apr 24, 2024 | — | $5.52M | — | -$0.42 | -$0.29 | +29.66% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$0.41 | -$0.40 | +3.25% | — | — |
| Q2 2023 Apr 26, 2023 | — | — | — | — | -$0.38 | — | — | — |
| Q4 2022 Oct 7, 2022 | — | — | — | — | -$0.12 | — | — | — |
| Q2 2022 May 4, 2022 | — | — | — | — | -$0.11 | — | — | — |
| Q4 2021 Dec 15, 2021 | — | — | — | — | -$0.33 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.26 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.19 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.14 | — | — | — |